Tsoi, Alexander http://orcid.org/0009-0004-4815-7477
Gomez, Alvaro http://orcid.org/0000-0001-9618-1755
Boström, Carina http://orcid.org/0000-0002-2506-687X
Pezzella, Denise
Chow, Jun Weng
Girard-Guyonvarc’h, Charlotte http://orcid.org/0000-0002-4901-2059
Stamm, Tanja http://orcid.org/0000-0003-3073-7284
Arnaud, Laurent http://orcid.org/0000-0002-8077-8394
Parodis, Ioannis http://orcid.org/0000-0002-4875-5395
Funding for this research was provided by:
Stiftelsen Konung Gustaf V:s 80-årsfond (FAI-2020-0741)
Swedish Rheumatism Association (R-969696)
Nyckelfonden (OLL-974804)
Swedish society of medicine (SLS-974449)
Stiftelsen Professor Nanna Svartz Fond (2021-00435)
Karolinska Institutet
Region Stockholm (FoUI-955483)
Ulla and Roland Gustafsson Foundation (2021 - 26)
Norrbacka-Eugeniastiftelsen
Karolinska Institute
Article History
Received: 27 November 2023
Accepted: 24 January 2024
First Online: 7 March 2024
Declarations
:
: IP has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia, Bristol-Myers Squibb, Elli Lilly, Gilead, GlaxoSmithKline, Janssen, Novartis, Otsuka, and Roche. All other authors declare that they have no conflicts of interest. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.